LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Alpelisib
0.1
1.95 27.76 408 225 1.8122 1.4352
MN20160318_Q01
M16
MCF 10A-H2B-mCherry Etoposide
0.1
14.58 84.90 1189 663 1.7923 1.4348
MN20160318_Q02
I13
MCF 10A-H2B-mCherry
0
8.76 27.76 856 401 2.1339 1.4348
MN20160318_Q01
F18
MCF 10A-H2B-mCherry Etoposide
0.31623
14.58 84.90 1189 663 1.7923 1.4348
MN20160318_Q02
M06
MCF 10A-H2B-mCherry
0
7.06 27.76 745 360 2.0694 1.4348
MN20160318_Q01
C17
MCF 10A-H2B-mCherry
0
16.29 84.90 1432 766 1.8674 1.4347
MN20160318_Q02
I06
MCF 10A-H2B-mCherry Neratinib
0.31623
9.47 84.90 717 447 1.6025 1.4347
MN20160318_Q02
E08
MCF 10A-H2B-mCherry Taxol
0.0056234
3.66 27.76 549 283 1.9336 1.4344
MN20160318_Q01
C16
MCF 10A-H2B-mCherry Palbociclib
5.6234
12.88 84.90 893 531 1.6817 1.4344
MN20160318_Q02
M18
MCF 10A-H2B-mCherry Alpelisib
0.0033333
14.58 84.90 1188 663 1.7908 1.4341
MN20160318_Q02
J09
MCF 10A-H2B-mCherry Neratinib
0.00043333
10.46 27.76 959 438 2.1863 1.4341
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Etoposide
1
7.06 27.76 744 360 2.0667 1.4339
MN20160318_Q01
F03
MCF 10A-H2B-mCherry Vorinostat
10
5.36 27.76 640 320 1.9978 1.4333
MN20160318_Q01
E19
MCF 10A-H2B-mCherry Trametinib
0.1
12.88 84.90 892 531 1.6798 1.4333
MN20160318_Q02
F07
MCF 10A-H2B-mCherry Vorinostat
0.56234
8.76 27.76 854 401 2.1289 1.4333
MN20160318_Q01
L20
MCF 10A-H2B-mCherry Alpelisib
0.01
12.17 27.76 1101 489 2.2512 1.4332
MN20160318_Q01
J03
MCF 10A-H2B-mCherry Dasatinib
0.31623
3.66 27.76 548 283 1.9301 1.4331
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Neratinib
0.056234
7.06 27.76 743 360 2.0639 1.4330
MN20160318_Q01
I13
MCF 10A-H2B-mCherry Palbociclib
0.1
10.46 27.76 957 438 2.1817 1.4328
MN20160318_Q01
L10
MCF 10A-H2B-mCherry Trametinib
1
10.46 27.76 957 438 2.1817 1.4328
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Neratinib
0.1
5.36 27.76 639 320 1.9946 1.4323
MN20160318_Q01
D18
MCF 10A-H2B-mCherry Vorinostat
3.1623
7.06 27.76 742 360 2.0611 1.4322
MN20160318_Q01
C15
MCF 10A-H2B-mCherry Dasatinib
0.056667
3.66 27.76 547 283 1.9265 1.4318
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
1
3.66 27.76 547 283 1.9265 1.4318
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
0.031667
12.17 27.76 1098 489 2.2451 1.4316
MN20160318_Q01
I15